Genesco (NYSE:GCO - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a report issued on Monday.
Genesco Stock Performance
NYSE GCO traded down $0.24 during trading hours on Monday, hitting $18.66. The company had a trading volume of 352,835 shares, compared to its average volume of 198,010. The business has a fifty day simple moving average of $28.45 and a 200-day simple moving average of $32.82. The firm has a market cap of $205.99 million, a P/E ratio of -7.68 and a beta of 2.25. The company has a quick ratio of 0.32, a current ratio of 1.56 and a debt-to-equity ratio of 0.19. Genesco has a fifty-two week low of $16.19 and a fifty-two week high of $44.80.
Genesco (NYSE:GCO - Get Free Report) last released its quarterly earnings results on Friday, March 7th. The company reported $3.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.31 by ($0.05). The business had revenue of $745.95 million during the quarter, compared to the consensus estimate of $780.43 million. Genesco had a positive return on equity of 0.56% and a negative net margin of 1.13%. During the same period in the previous year, the company posted $2.59 EPS. Equities analysts predict that Genesco will post 0.94 EPS for the current year.
Insider Transactions at Genesco
In other Genesco news, major shareholder Fund 1 Investments, Llc sold 12,000 shares of the stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $20.73, for a total value of $248,760.00. Following the completion of the sale, the insider now owns 1,097,850 shares in the company, valued at $22,758,430.50. This represents a 1.08 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gregory A. Sandfort bought 10,974 shares of the stock in a transaction on Thursday, March 20th. The stock was purchased at an average price of $22.92 per share, for a total transaction of $251,524.08. Following the purchase, the director now directly owns 26,754 shares of the company's stock, valued at approximately $613,201.68. This represents a 69.54 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 7.09% of the company's stock.
Institutional Trading of Genesco
A number of institutional investors have recently added to or reduced their stakes in GCO. Portolan Capital Management LLC bought a new stake in Genesco during the fourth quarter valued at about $19,847,000. Fund 1 Investments LLC raised its stake in Genesco by 1,045.4% during the fourth quarter. Fund 1 Investments LLC now owns 242,965 shares of the company's stock worth $10,387,000 after acquiring an additional 221,752 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Genesco by 124.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 251,142 shares of the company's stock worth $6,824,000 after acquiring an additional 139,485 shares in the last quarter. Marshall Wace LLP lifted its position in Genesco by 28.6% during the 4th quarter. Marshall Wace LLP now owns 428,143 shares of the company's stock worth $18,303,000 after buying an additional 95,195 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Genesco by 25.3% in the fourth quarter. American Century Companies Inc. now owns 276,807 shares of the company's stock valued at $11,833,000 after purchasing an additional 55,977 shares in the last quarter. 94.51% of the stock is currently owned by institutional investors and hedge funds.
Genesco Company Profile
(
Get Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Featured Stories
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
